Eclira Genuair 400 microgram (Aclidinium Bromide (Micronized))

Adult use

Inhale 400 μg (1 dose) of Aclidinium Bromide twice a day.

Child use

Not to be administered to children under 18 years.

This medication should not be used as an emergency drug for the treatment of acute bronchospasm. An immediate hypersensitivity reaction may occur after administration, and if such symptoms arise, drug use should be immediately discontinued and alternative therapy sought. This medication may rarely cause fatal bronchoconstriction; therefore, if such symptoms occur, use should be immediately stopped and a doctor consulted. Individuals with conditions such as glaucoma, benign prostatic hyperplasia, or bladder obstruction should exercise special caution when using this drug and should stop use immediately and consult a doctor if related symptoms occur. Prolonged dry mouth may increase the risk of cavities, so oral hygiene should be maintained. Patients who have an allergy to the components of this drug or certain genetic issues should not use it. Patients with heart disease or severe heart failure should also carefully consider the use of this medication. Common side effects may include headache, rhinitis, cough, nausea, dry mouth, etc. Serious side effects can occur rarely, so if abnormal symptoms persist, medical staff should be notified immediately. Use with other anticholinergics is not recommended; however, it may be combined with certain treatments for lung diseases. Caution should be taken as dizziness or blurred vision may occur while driving or operating machinery. The safety of this drug during pregnancy has not been established; it should be used cautiously only when necessary, and during breastfeeding, a decision should be made after consulting a doctor. Use in children under 18 years is not recommended due to insufficient experience. Overdose may result in anticholinergic symptoms, but serious adverse reactions are rare at normal dosages. This medication should be inhaled as directed, and following the instructions accurately is necessary for effectiveness. When storing, keep it out of reach of children and ensure it is not transferred to another container.

Serious side effects

Immediate hypersensitivity reaction, angioedema, symptoms of narrow-angle glaucoma (eye pain, blurred vision, redness, halos, coloration), urinary retention, paradoxical bronchospasm, dyspnea, asthma exacerbation, anaphylaxis, pneumonia, worsened pneumonia, loss of lung function, acute respiratory distress syndrome, generalized edema, worsening chest pain, malignant neoplasms, facial paralysis, seizures, coronary artery disease exacerbation, atrial fibrillation exacerbation, atrial fibrillation, deep vein thrombosis, urticaria

Mild side effects

• Headache
• nasopharyngitis
• sinusitis
• tachycardia
• arrhythmias
• cough
• voice disorders
• diarrhea
• nausea
• dry mouth

This medication should be stored in an airtight container that allows for good ventilation and kept at a temperature between 1 to 30 degrees Celsius at room temperature. Storing it this way will help maintain the drug's effectiveness for a longer time.

Appearance

A metered dry powder inhaler filled with white or nearly white inhalation powder

Package unit

60 doses/1 inhaler (Genuair)